Anika Therapeutics (ANIK) Misses Q2 EPS by 5c
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $15.78 +2.73%
EPS Growth %: +115.4%
Financial Fact:
Provision for income taxes: 4.83M
Today's EPS Names:
CRMT, PKE, More
EPS Growth %: +115.4%
Financial Fact:
Provision for income taxes: 4.83M
Today's EPS Names:
CRMT, PKE, More
Join SI Premium – FREE
Anika Therapeutics (NASDAQ: ANIK) reported Q2 EPS of ($0.13), $0.05 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $28.22 million versus the consensus estimate of $28.15 million.
For earnings history and earnings-related data on Anika Therapeutics (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ArcelorMittal (MT:NA) (MT) PT Raised to EUR65 at Jefferies
- Barclays Upgrades Legrand SA (LR:FP) (LGRDY) to Overweight
- Unum Group (UNM) PT Lowered to $100 at Wolfe Research
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
